<DOC>
	<DOCNO>NCT00700206</DOCNO>
	<brief_summary>This randomize , open label , multicenter , Phase 2 study compare two dose schedule Telintra patient Low Intermediate-1 risk MDS . Patients least 18 year age present histologically confirm Low Intermediate-1 risk MDS document significant cytopenia least two month IWG criterion eligible .</brief_summary>
	<brief_title>Phase 2 Study Comparing Two Dose Schedules Telintraâ„¢ Myelodysplastic Syndrome ( MDS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Primary de novo MDS Low intermediate1 MDS ECOG performance status 0 1 Documented significant anemia without neutropenia and/or thrombocytopenia Adequate kidney liver function Patients must discontinue hematopoietic growth factor least 3 week prior study entry Prior allogenic bone marrow transplant MDS History MDS IPSS score great 1.0 Pregnant lactate woman Any severe concurrent disease , infection , comorbidity , judgement investigator , would make patient inappropriate study entry Oral steroid e.g . prednisone &gt; 10 mg per day History active hepatitis B C Known history HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Hematology</keyword>
	<keyword>MDS</keyword>
	<keyword>Myelodysplastic Syndrome</keyword>
	<keyword>Low Risk MDS</keyword>
	<keyword>Intermediate-1 risk MDS</keyword>
	<keyword>Int-1 risk MDS</keyword>
	<keyword>Telintra</keyword>
	<keyword>ezatiostat hydrochloride</keyword>
	<keyword>ezatiostat</keyword>
	<keyword>TLK199</keyword>
	<keyword>Glutathione</keyword>
	<keyword>Glutathione analog</keyword>
	<keyword>Glutathione Transferase</keyword>
	<keyword>Glutathione Transferase inhibitor</keyword>
	<keyword>Glutathione Transferase P1-1 inhibitor</keyword>
	<keyword>GSTp1-1 inhibitor</keyword>
	<keyword>Apoptosis</keyword>
	<keyword>Differentiation</keyword>
	<keyword>Enzyme inhibitor</keyword>
</DOC>